Testing fluid biomarkers from a chest drain in pleural effusion
Part of Cancer, Lungs & breathing clinical trials.
This trial studies specific markers (biomarkers) found in fluid from a chest drain to better understand pleural effusions (fluid around the lungs), especially when fluid keeps coming back after treatment. You may be helped by contributing to research that could improve how these effusions are diagnosed and managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign consent.
- You have fluid around the lung (pleural effusion) that is due to cancer or is strongly linked to known cancer, with no other clear cause.
- Your symptoms (like shortness of breath, cough, or chest discomfort) improved after draining the fluid with a thoracentesis.
- The fluid returns again after that thoracentesis.
- Your health situation is not too severe—your expected survival is at least 30 days.
- You can safely manage the pleural catheter drainage at home and do the required drain care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects fluid that builds up around your lungs (pleural effusion) during a drainage procedure you already need. Researchers test how different drugs affect your cancer cells in the lab to help predict which treatments might work best for you.
This study collects information from patients with fluid buildup around the lungs (called pleural effusion) to better understand causes and outcomes. It may help improve care for future patients.
This study is looking at whether certain substances in the fluid around your lungs can help tell the difference between cancer and non-cancer causes of fluid buildup. It involves testing the fluid you already have drained, and could help guide your diagnosis.
This trial looks at how a breathing control system (called neural respiratory drive) changes when doctors remove lung lining fluid using a thoracocentesis, chest drain, or an indwelling pleural catheter. It may help improve how safe breathing measurements are taken during these common procedures.
This trial compares two ways to drain fluid that has built up around the lungs (pleural effusion) when it is not caused by injury. One method uses a thin, flexible tube (pigtail catheter), and the other uses a larger chest tube. The goal is to see which method works better and is more comfortable for patients.
This study is looking at certain substances in the fluid around the lungs (pleural effusion) of people with lung adenocarcinoma. It may help doctors understand this condition better and find new ways to treat it.
Hear when a new Malignant Pleural Effusions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.